In order to study structure-activity relationships among the derivatives and congeners of 5',9-anhydro-3-(beta-D-ribofuranosyl)xanthine for anti-hepatitis C virus activity, a series of 5',9-anhydro-purine-isonucleosides with a substituent (s) at 6- or/and 8-position of the purine moiety were synthesized, and their anti-hepatitis C virus activity and cytotoxicity were evaluated and discussed.
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents. Publishing Authors By Initials
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 100892832
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents. Keywords Mesh Terms:
KEYWORDS: Virus Replication
MESH TERMS: drug effects
Chemical & Substance for Abstract: Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents. Information
Substance Name: RNA, Viral
Registry Number: 0
Grant and Affiliation Information for Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents.
AFFILIATION: Pharmasset, Inc., Princeton, New Jersey 08540, USA. kwon.chun@pharmasset.com
Country: United States
AGENCY: United States NIAID
GRANT: 1R43AI-056720
ACRONYM: AI
MEDLINETA: Nucleosides Nucleotides Nuclei
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents Related Publications